Pennington, NJ, United States of America

Robert Zahler

USPTO Granted Patents = 74 (Patent Applications = 24)

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 17 (Patent Applications = 28)

Average Co-Inventor Count = 3.2

ph-index = 14

Forward Citations = 529(Granted Patents)

Inventors with similar research interests:

Location History:

Princeton, NJ (US) (1985 - 1998)
Pennington, NJ (US) (1993 - 2023)

Company Filing History:

29 out of 1,624

E. R. Squibb Sons, Inc.

Agios Pharmaceuticals, Inc.

patents

4. 3 out of 3,681

Bristol-myers Squibb Compnay

patents

5. 3 out of 17

Tetraphase Pharmaceuticals, Inc.

patents

6. 2 out of 15

Advinus Therapeutics Private Limited

patents

7. 2 out of 118

Osi Pharmaceuticals, Inc.

patents

8. 2 out of 15

Morphic Therapeutic, Inc.

patents

9. 2 out of 21

Servier Pharmaceuticals LLC

patents

10. 1 out of 48

Piramal Enterprises Limited

patents

11. 1 out of 805

National University of Singapore

patents

12. 1 out of 2,882

The General Hospital Corporation

patents

13. 1 out of 123

Institut National De La Recherche Scientifique

Years Active: 1985-2025

Loading Chart...

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433895 - Therapeutically active compounds and their methods of use (2025-10-07),

2. 11844758 - Therapeutically active compounds and their methods of use (2023-12-19),

3. 11370773 - Inhibiting human integrin (alpha-4) (beta-7) (2022-06-28),

4. 11104661 - Inhibiting human integrin (α-4) (β-7) (2021-08-31),

5. 10946023 - Therapeutically active compounds and their methods of use (2021-03-16),

6. 10220015 - Fumigillol compounds and methods of making and using same (2019-03-05),

7. 10175256 - Compositions and methods utilizing lysophosphatidylcholine scaffolds (2019-01-08),

8. 10174009 - Tricyclic sulphonamide compounds and methods of making and using same (2019-01-08),

9. 10172864 - Therapeutically active compounds and their methods of use (2019-01-08),

10. 10028961 - Therapeutically active compounds and their methods of use (2018-07-24),

11. 10023561 - Fumagillol heterocyclic compounds and methods of making and using same (2018-07-17),

12. 9944613 - Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using same (2018-04-17),

13. 9895339 - Fumigillol compounds and methods of making and using same (2018-02-20),

14. 9868717 - Tricyclic sulphonamide compounds and methods of making and using same (2018-01-16),

15. 9839623 - Tricyclic compounds and methods of making and using same (2017-12-12),

Title: The Inventor Profile of Robert Zahler

Introduction: Robert Zahler is a distinguished inventor based in Pennington, NJ (US) known for his groundbreaking contributions to various fields.

Latest Patents: Robert Zahler holds several patents in the areas of technology and engineering, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: With a career spanning over two decades, Robert Zahler has worked on numerous projects that have revolutionized industries and improved existing technologies.

Collaborations: Throughout his career, Robert Zahler has collaborated with leading experts in the field, fostering a culture of innovation and knowledge-sharing.

Conclusion: Robert Zahler's passion for innovation and his dedication to pushing the boundaries of what is possible make him a standout figure in the world of inventors.

This text is generated by artificial intelligence and may not be accurate.